# Polypill in Acute Coronary Syndrome

Study · id `cardio:ct-nct05514938` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05514938](<https://clinicaltrials.gov/study/NCT05514938>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05514938

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.

## Technical summary

Registry record NCT05514938. Randomized; no masking; primary purpose treatment. Start 2022-11-30 (actual); primary completion 2025-05-30 (actual). Results posted on 2026-05-14.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 140 participants (enrolled count; ClinicalTrials.gov record NCT05514938, source copy `cardio:ctgov-nct05514938-2026-09-22`, retrieved 2026-10-26)
- Started: 2022-11-30 (actual) (ClinicalTrials.gov record NCT05514938, source copy `cardio:ctgov-nct05514938-2026-09-22`, retrieved 2026-10-26)
- Primary completion: 2025-05-30 (actual) (ClinicalTrials.gov record NCT05514938, source copy `cardio:ctgov-nct05514938-2026-09-22`, retrieved 2026-10-26)
- Completion: 2025-06-05 (actual) (ClinicalTrials.gov record NCT05514938, source copy `cardio:ctgov-nct05514938-2026-09-22`, retrieved 2026-10-26)
- Results first posted: 2026-05-14 (ClinicalTrials.gov record NCT05514938, source copy `cardio:ctgov-nct05514938-2026-09-22`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05514938, source copy `cardio:ctgov-nct05514938-2026-09-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05514938-2026-09-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Polypill in Acute Coronary Syndrome
- Acronym: POLY-ACS
- Condition: Acute Coronary Syndrome
- Condition: Lipid Disorder
- Condition: Coronary Artery Disease
- Intervention (Drug): Polypill
- Intervention (Drug): Usual Care (individual medications prescribed by primary cardiologist)
- Lead sponsor: University of Texas Southwestern Medical Center
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: University of Texas Southwestern Medical Center (`cardio:org-university-of-texas-southwestern-medical-center`)

## Provenance

Content hash: 05306b953d284c0a0594be47e67cb778469e52942578494d8415a61f9a291776
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
